Peptide record

TPDB92534

iRGD Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92534
iRGD
Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Cancer-related peptides Delivery and barrier-penetrating peptides
Peptipedia BBPpredict CPPsite3.0 MLCPP 2.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 9-aa modified multi-activity (Anticancer, Blood-Brain Barrier, Cell-penetrating Peptides, and other sources) peptide sequence curated from Peptipedia, BBPpredict, CPPsite3.0, and other sources, with an available 3D structural model.
N-terminal: ST-4
Sequence
CRGDKGPDC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
CendR (R/KXXXR/K), RGD Activity
ST-4 Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor vascular endothelium, tumor cell
Targeting
Multiple tumor
Integrin αv, Neuropilin-1

Source & Reference

TumorHoPe2.0
TumorHoPe2
An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy
2020
Song Y et al. Int J Pharm. 2020 Aug 30:586:119498.

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
B16F10, 4T1
B16F10 tumor-bearing C57BL/6 mice and 4T1 tumor-bearing BALB/c mice
Synthetic
Superantigen mutant ST-4
Additional Detail Fields 3 fields
Superantigen mutant ST-4
B16F10, 4T1
B16F10 tumor-bearing C57BL/6 mice and 4T1 tumor-bearing BALB/c mice